Preferred Label : olsalazine;
MeSH note : cpd with 2 salicylate molecules linked together by an azo bond; when given orally,
liberates 5-aminosalicylic acid in colonic lumen; potential for treatment of ulcerative
colitis; confusing synonym sodium diazosalicylate from letter in JAMA 1982;248(8):924;
RN given refers to parent cpd;
CISMeF synonym : celltech brand of olsalazine sodium; pharmacia brand of olsalazine sodium; CJ-91B; dipentum; ipsen brand of olsalazine sodium; pfizer brand of olsalazine; rasal;
MeSH synonym : azodisalicylate;
MeSH hyponym : disodium 5,5'-azodisalicylate; sodium diazosalicylate; olsalazine, disodium salt; azodisal sodium; disodium azodisalicylate;
MeSH CAS label : benzoic acid, 3,3'-azobis(6-hydroxy)-,;
MeSH Related Number : olsalazine sodium; 15722-48-2 (olsalazine); 6054-98-4 (di-Na salt); Y7JEW0XG7I;
Registry Number MeSH : 15722-48-2;
Related CAS MeSH : 6054-98-4 (olsalazine sodium);
related registry number list (CISMeF) : 6054-98-4 (di-Na salt);
CISMeF hyponym : olsalazine sodique;
Is substance : O;
UNII : ULS5I8J03O;
InChIKey : QQBDLJCYGRGAKP-FOCLMDBBSA-N;
Origin ID : C032587;
UMLS CUI : C0069454;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Validated automatic mappings to NTBT
https://www.has-sante.fr/portail/jcms/c_2829388/fr/dipentum
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
olsalazine
olsalazine sodium
olsalazine
aminosalicylic acids
---
http://www.lecrat.eu/?s=Olsalazine
2014
false
France
French
pregnancy
aminosalicylic acids
anti-inflammatory agents, non-steroidal
gastrointestinal agents
olsalazine
olsalazine
aminosalicylic acids
drug information
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-10/dipentum_-_ct-_11453.pdf
http://www.has-sante.fr/portail/jcms/c_1104007/dipentum
2011
France
French
olsalazine
administration, oral
anti-inflammatory agents, non-steroidal
gastrointestinal agents
olsalazine
insurance, health, reimbursement
colitis, ulcerative
aminosalicylic acids
aminosalicylic acids
olsalazine
treatment outcome
olsalazine sodium
evaluation of the transparency committee
---